Drug Approval | December 12, 2022
Alembic receives USFDA final Approval for Desonide Cream
Desonide Cream, 0.05%, has an estimated market size of US $12 million for twelve months ending Sep 2022 according to IQVIA
Desonide Cream, 0.05%, has an estimated market size of US $12 million for twelve months ending Sep 2022 according to IQVIA
They also released the Operational Guidelines for Wellness activities at AB-HWCs
Since inception, more than 3.6 crore pregnant women have received comprehensive ANC under this programme across all states and UTs
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
With this QIP placement, the Dhanuka group, which took over the company in 2018, is also meeting its mandatory obligation to dilute 15 percent stake in the company by March 2023
South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe
40,000 visitors and representatives of more than 80 countries set to visit the show
Approval broadens indication for ENHERTU to earlier use in metastatic breast cancer and requirement for confirmatory phase 3 trial
Joint Drugs Controller (India) Dr PBN Prasad shared his views about working during harsh COVID-19 pandemic days
Subscribe To Our Newsletter & Stay Updated
